Get the App
A

Adverum Biotechnologies (ADVM)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Adverum Biotechnologies (ADVM)

Adverum Biotechnologies, Inc. operates as a biotechnology company. The Company focuses on targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitrea... Read more

  • 0.67
  • 0.67
  • 0.63
  • 2.04
  • -19.9%
  • --
  • 0.00
  • 721.00k
  • 66M
  • 0.63
  • -63.8%
  • %

Stock News

Need to Know: BlackRock says the market is misjudging these key risks. Here’s its advice on stocks and bonds.

50 minutes ago

Need to Know: BlackRock says the market is misjudging these key risks. Here’s its advice on stocks and bonds.

MarketWatch

: More than half of renters think they’ll never be able to own a home, survey says. Here’s why.

1 hour ago

: More than half of renters think they’ll never be able to own a home, survey says. Here’s why.

MarketWatch

: Women need to save more, earlier and invest more aggressively for retirement – here’s why

1 hour ago

: Women need to save more, earlier and invest more aggressively for retirement – here’s why

MarketWatch

Surviving Covid Was Just the Beginning of the Battle

1 hour ago

Surviving Covid Was Just the Beginning of the Battle

Bloomberg

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium